4 search results for: orestis-mavroudis-chocholis

On February 22, 2017, the European Commission (EC), following the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human...

The immune checkpoint inhibitor buzz began almost 3 years ago to the day, with the first presentation of Opdivo data from a Phase I trial, at the...

Non-small-cell lung cancer (NSCLC) is considered by many to be the poster child for personalized medicine in oncology. The approval of tyrosine...

ASCO 2013 Impressions Presentations regarding the use of Avastin in glioblastoma (GBM) were prominent in the Central Nervous System Cancer and...